Home/Filings/4/0001493152-23-005078
4//SEC Filing

Hoitt Jason 4

Accession 0001493152-23-005078

CIK 0001695357other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 7:16 PM ET

Size

5.3 KB

Accession

0001493152-23-005078

Insider Transaction Report

Form 4
Period: 2023-02-10
Hoitt Jason
Chief Commercial Officer
Transactions
  • Sale

    Common Stock

    2023-02-10$10.00/sh4,500$45,0050 total
Footnotes (2)
  • [F1]The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2022.
  • [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.02 per share, inclusive. The reporting person undertakes to provide to Provention Bio, Inc., any security holder of Provention Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Documents

1 file

Issuer

Provention Bio, Inc.

CIK 0001695357

Entity typeother

Related Parties

1
  • filerCIK 0001762572

Filing Metadata

Form type
4
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 7:16 PM ET
Size
5.3 KB